Bruce C Bostrom (Bruce Bostrom)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 7

Top Topics

Diffuse Large B Cell Lymphoma

Allergic Rhinitis

Acute Lymphoblastic Leukemia

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Linea Natalie Toksvang, Kathrine Grell, Jacob Nersting, Matilda Degn, Stine N Nielsen, Jonas Abrahamsson, Bendik Lund, Jukka Kanerva, Ólafur G Jónsson, Kristi Lepik, Goda Vaitkevičienė, Laimonas Griškevičius, Petter Quist-Paulsen, Ajay Vora, Anthony V Moorman, Daniel Murdy, Martin Zimmermann, Anja Möricke, Bruce C Bostrom, Jaitri Joshi, Lisa L Hjalgrim, Kim P Dalhoff, Bodil Als-Nielsen, Kjeld Schmiegelow
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis. Leukemia (2021)
Yoav H Messinger, Bruce C Bostrom, Damon R Olson, Nathan P Gossai, Lane H Miller, Michael K Richards
Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib. Pediatric blood & cancer 67 (12) (2020)
Bruce C Bostrom
Comment on: "Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemia: An ounce of prevention is worth a pound of cure: Consideration of prophylactic pamidronate. Pediatric blood & cancer 68 (3) (2020)
Michael Losasso, Bruce C Bostrom, Yoav H Messinger
Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. F1000Research 8 (2019)
Melissa Zhang, Bruce C Bostrom
Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia. F1000Research 8 (2019)
Yoav H Messinger, Bruce C Bostrom
Bortezomib-based four-drug induction does induce a response in advanced relapsed ALL but cure remains elusive. Pediatric blood & cancer 67 (3) (2019)
Melissa Zhang, Bruce C Bostrom
Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia. F1000Research (2019)